unknown
Stage
About
BRC Therapeutics develops prescription medicines based on cannabinoids to address pain and neurological and inflammatory conditions, currently running clinical trials for Complex Regional Pain Syndrome and Aromatase Inhibitor-Induced Arthralgia.
Explore BRC Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.